How to Image Cardiac Amyloidosis A Practical Approach

被引：181

作者：

Dorbala, Sharmila ^{[1
,2
,3
]}

Cuddy, Sarah ^{[1
,2
,3
]}

Falk, Rodney H. ^{[3
]}

机构：

[1] Brigham & Womens Hosp, Dept Radiol, Div Nucl Med, 75 Francis St, Boston, MA 02115 USA

[2] Brigham & Womens Hosp, Cardiovasc Div, CV Imaging Program, 75 Francis St, Boston, MA 02115 USA

[3] Brigham & Womens Hosp, Dept Med, Div Cardiol, Cardiac Amyloidosis Program, Boston, MA USA

来源：

JACC-CARDIOVASCULAR IMAGING | 2020年 / 13卷 / 06期

基金：

美国国家卫生研究院;

关键词：

amyloid tracers; cardiac amyloidosis; cardiac magnetic resonance; CMR; echocardiography; imaging; multimodality; radionuclide imaging; PET; pyrophosphate; Tc-99m-PYP; AL AMYLOIDOSIS; SYSTEMIC AMYLOIDOSIS; MAGNETIC-RESONANCE; HEART-FAILURE; MICROVASCULAR DYSFUNCTION; LIGHT-CHAINS; TRANSTHYRETIN; DIAGNOSIS; CMR; QUANTIFICATION;

D O I：

10.1016/j.jcmg.2019.07.015

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiac amyloidosis (CA) is one of the most rapidly progressive forms of heart disease, with a median survival from diagnosis, if untreated, ranging from <6 months for light chain amyloidosis to 3 to 5 years for transthyretin amyloidosis. Early diagnosis and accurate typing of CA are necessary for optimal management of these patients. Emerging novel disease modifying therapies increase the urgency to diagnose CA at an early stage and identify patients who may benefit from these life-saving therapies. The goal of this review is to provide a practical approach to echocardiography, cardiac magnetic resonance, and radionuclide imaging in patients with known or suspected CA. (c) 2020 by the American College of Cardiology Foundation.

引用

页码：1368 / 1383

页数：16

共 76 条

[1] Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis [J].

Adams, D. ;

Gonzalez-Duarte, A. ;

O'Riordan, W. D. ;

Yang, C. -C. ;

Ueda, M. ;

Kristen, A. V. ;

Tournev, I. ;

Schmidt, H. H. ;

Coelho, T. ;

Berk, J. L. ;

Lin, K. -P. ;

Vita, G. ;

Attarian, S. ;

Plante-Bordeneuve, V. ;

Mezei, M. M. ;

Campistol, J. M. ;

Buades, J. ;

Brannagan, T. H., III ;

Kim, B. J. ;

Oh, J. ;

Parman, Y. ;

Sekijima, Y. ;

Hawkins, P. N. ;

Solomon, S. D. ;

Polydefkis, M. ;

Dyck, P. J. ;

Gandhi, P. J. ;

Goyal, S. ;

Chen, J. ;

Strahs, A. L. ;

Nochur, S. V. ;

Sweetser, M. T. ;

Garg, P. P. ;

Vaishnaw, A. K. ;

Gollob, J. A. ;

Suhr, O. B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) :11-21

[2] In Vivo Visualization of Amyloid Deposits in the Heart with 11C-PIB and PET [J].

Antoni, Gunnar ;

Lubberink, Mark ;

Estrada, Sergio ;

Axelsson, Jan ;

Carlson, Kristina ;

Lindsjo, Lars ;

Kero, Tanja ;

Langstrom, Bengt ;

Granstam, Sven-Olof ;

Rosengren, Sara ;

Vedin, Ola ;

Wassberg, Cecilia ;

Wikstrom, Gerhard ;

Westermark, Per ;

Sorensen, Jens .

JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (02) :213-220

[3] Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin [J].

Aprile, C ;

Marinone, G ;

Saponaro, R ;

Bonino, C ;

Merlini, G .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1995, 22 (12) :1393-1401

[4] T1 mapping and survival in systemic light-chain amyloidosis [J].

Banypersad, Sanjay M. ;

Fontana, Marianna ;

Maestrini, Viviana ;

Sado, Daniel M. ;

Captur, Gabriella ;

Petrie, Aviva ;

Piechnik, Stefan K. ;

Whelan, Carol J. ;

Herrey, Anna S. ;

Gillmore, Julian D. ;

Lachmann, Helen J. ;

Wechalekar, Ashutosh D. ;

Hawkins, Philip N. ;

Moon, James C. .

EUROPEAN HEART JOURNAL, 2015, 36 (04) :244-251

[5] Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis An Equilibrium Contrast Cardiovascular Magnetic Resonance Study [J].

Banypersad, Sanjay M. ;

Sado, Daniel M. ;

Flett, Andrew S. ;

Gibbs, Simon D. J. ;

Pinney, Jennifer H. ;

Maestrini, Viviana ;

Cox, Andrew T. ;

Fontana, Marianna ;

Whelan, Carol J. ;

Wechalekar, Ashutosh D. ;

Hawkins, Philip N. ;

Moon, James C. .

CIRCULATION-CARDIOVASCULAR IMAGING, 2013, 6 (01) :34-39

[6] Comparison of right ventricular longitudinal strain imaging, tricuspid annular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohort study [J].

Bellavia, Diego ;

Pellikka, Patricia A. ;

Dispenzieri, Angela ;

Scott, Christopher G. ;

Al-Zahrani, Ghormallah B. ;

Grogan, Martha ;

Pitrolo, Francesco ;

Oh, Jae K. ;

Miller, Fletcher A., Jr. .

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2012, 13 (08) :680-689

[7] Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis [J].

Benson, M. D. ;

Waddington-Cruz, M. ;

Berk, J. L. ;

Polydefkis, M. ;

Dyck, P. J. ;

Wang, A. K. ;

Plante-Bordeneuve, V. ;

Barroso, F. A. ;

Merlini, G. ;

Obici, L. ;

Scheinberg, M. ;

Brannagan, T. H., III ;

Litchy, W. J. ;

Whelan, C. ;

Drachman, B. M. ;

Adams, D. ;

Heitner, S. B. ;

Conceicao, I. ;

Schmidt, H. H. ;

Vita, G. ;

Campistol, J. M. ;

Gamez, J. ;

Gorevic, P. D. ;

Gane, E. ;

Shah, A. M. ;

Solomon, S. D. ;

Monia, B. P. ;

Hughes, S. G. ;

Kwoh, T. J. ;

McEvoy, B. W. ;

Jung, S. W. ;

Baker, B. F. ;

Ackermann, E. J. ;

Gertz, M. A. ;

Coelho, T. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) :22-31

[8] MYOCARDIAL TEXTURE CHARACTERIZATION BY TWO-DIMENSIONAL ECHOCARDIOGRAPHY [J].

BHANDARI, AK ;

NANDA, NC .

AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (05) :817-825

[9] Molecular mechanism of Thioflavin-T binding to amyloid fibrils [J].

Biancalana, Matthew ;

Koide, Shohei .

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2010, 1804 (07) :1405-1412

[10] Matrix Metalloproteinases and Their Tissue Inhibitors in Cardiac Amyloidosis Relationship to Structural, Functional Myocardial Changes and to Light Chain Amyloid Deposition [J].

Biolo, Andreia ;

Ramamurthy, Sujata ;

Connors, Lawreen H. ;

O'Hara, Carl J. ;

Meier-Ewert, Hans K. ;

Hoo, Pamela T. Soo ;

Sawyer, Douglas B. ;

Seldin, David S. ;

Sam, Flora .

CIRCULATION-HEART FAILURE, 2008, 1 (04) :249-257

← 1 2 3 4 5 6 7 8 →